All-new Advanced CAR-T Treatment Might Give Hope to the Cancer Patients

61

Judy Wilkins had tried as many as four different chemotherapy sessions for eradicating her cancer. After bleak expectations, Wilkins had to face the reality that she might have only a few months to live. It was then that her cancer care & research team at Dana-Farber/Brigham & Women’s Cancer Center tried introducing her to a new form of advanced cancer treatment referred to as the “CAR-T” Cell Therapy. With the help of this revolutionary immunotherapy treatment, Wilkins is now cancer free.

Dana-Farber happens to be the only cancer research center in New England that offers the nation-wide clinic trials of the innovative CAR T-cell Therapy treatment. CAR (shot form for “Chimeric Antigen Receptor) T-Cell Therapy treatment is a type of cellular treatment therapy that makes use of the self-immune system of the patient towards rallying an attack on the cancer cells. The T blood cells (white blood cells) are programmed in a manner that they start killing the cancer cells. The T cells are removed from the blood of the patient and engineered for sprouting special structures referred to as CARs (Chimeric Antigen Receptors) on the subsequent surface. When the T blood cells are re-infused into the patient’s system, the CAR T-cells are then able to identify & kill the cancer cells.

In the period of the past five years, the revolutionary treatment of CAR T-cell Therapy has emerged to be a potentially effective treatment for some cancer patients –some with bladder cancer, blood cancer, and others. The FDA (Food & Drug Administration) of the USA recently gave the first-ever approval to the advanced CAR T-Cell Therapy treatment for treating the young adults having B-cell ALL (Acute Lymphoblastic Leukemia).